Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2009

Gray Stacy W, O'Grady Cristin, Karp Lauren, Smith Daniel, Schwartz J Sanford, Hornik Robert C, Armstrong Katrina

Abstract excerpt

BACKGROUND: Direct-to-consumer (DTC) BRCA testing may expand access to genetic testing and enhance cancer prevention efforts. It is not known, however, if current DTC websites provide adequate risk information for informed medical decision making. METHODS: A total of 284 women with a personal or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude to Health
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Making

Share to Genes, BRCA1

Share to Genetic Counseling

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 19318436
DOI: 10.1158/1055-9965.EPI-08-0825
PMCID: PMC2963112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19318436-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.PMID 19318436Read ↗

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.Semantic proximity Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

The Breast Cancer Genetic Testing Experience: Probing the Potential Utility of an Online Decision Aid in Risk Perception and Decision MakingSemantic proximity Read ↗

The Pink Underside: The Commercialization of Medical Risk Assessment and Decision-Making Tools for Hereditary Breast Cancer Risk.Semantic proximity Read ↗

The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making.Semantic proximity Read ↗

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read ↗

BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”.Semantic proximity Read ↗

Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.